AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00994-06v1
51/3/864    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willemsen, I.
Right arrow Articles by Kluytmans, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willemsen, I.
Right arrow Articles by Kluytmans, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2007, p. 864-867, Vol. 51, No. 3
0066-4804/07/$08.00+0     doi:10.1128/AAC.00994-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Appropriateness of Antimicrobial Therapy Measured by Repeated Prevalence Surveys{triangledown}

Ina Willemsen,1 Anneke Groenhuijzen,2 Diana Bogaers,1 Arie Stuurman,3 Peter van Keulen,1 and Jan Kluytmans1*

Laboratory for Microbiology and Infection Control, Amphia Hospital, P.O. Box 90158 4800 RK, Breda, The Netherlands,1 Department of Pharmacy, Franciscus Hospital, Roosendaal, The Netherlands,2 Department of Pharmacy, Amphia Hospital, Breda, The Netherlands3

Received 9 August 2006/ Returned for modification 5 September 2006/ Accepted 26 December 2006

Prudent use of antibiotics is mandatory to control antibiotic resistance. The objective of this study was to determine if prevalence surveys are useful tools to determine the appropriateness of antimicrobial therapy (AMT) and determinants of inappropriate AMT. The study was performed in a 1,350-bed teaching hospital including all medical specialities. Six consecutive 1-day prevalence surveys of in-patients were performed twice yearly from 2001 to 2004. Data on the demographics, infections, and AMT were gathered. The appropriateness of AMT was assessed according to a standardized algorithm based on the local AMT prescription guidelines. On average, 684 patients were included in each survey (total, 4,105). The use of AMT as determined in the prevalence survey corresponded to the annual data from the pharmacy department. Nine hundred thirty-eight (22.9%) of the patients received AMT, and in 351 (37.4%) of these patients AMT was inappropriate. Only 25 (0.6%) patients did not receive AMT, although it was indicated. After multivariate analysis, the use of quinolones was the only statistically significant variable associated with inappropriate use. Prevalence surveys proved to be useful tools to judge the appropriateness of AMT and to identify determinants of inappropriate use. This study shows that in a setting with a low use of AMT, there are few patients who inadvertently do not receive AMT. On the other hand, a substantial number of the patients are treated inappropriate.


* Corresponding author. Mailing address: Laboratory for Microbiology and Infection Control, Amphia Hospital, P.O. Box 90158, 4800 RK Breda, The Netherlands. Phone: 31 76 5955238. Fax: 31 76 5953820. E-mail: iwillemsen{at}amphia.nl.

{triangledown} Published ahead of print on 8 January 2007.


Antimicrobial Agents and Chemotherapy, March 2007, p. 864-867, Vol. 51, No. 3
0066-4804/07/$08.00+0     doi:10.1128/AAC.00994-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.